Is Genome-editing CRISPR Ready to Leave the Lab? | Synced

The 2017 Harvard China Forum hosted a panel on “Futuristic Technologies & Innovations in AI and Biotech”, where Feng Zhang was invited to share insights on genome-editing.

By Omega Sentinel · March 16, 2026 · 1 min read

industry
united states
cancer immunotherapy
commercial funding
crispr

Source: Synced | AI Technology & Industry Review

The 2017 Harvard China Forum hosted a panel on “Futuristic Technologies & Innovations in AI and Biotech”, where Feng Zhang was invited to share insights on genome-editing.